Bridging Discovery and Early Development
Early decisions in formulation and delivery platform selection often define downstream success. A structured approach to transition can significantly reduce development risk and improve development efficiency.
Delivery Platforms: Fit-for-Purpose vs Platform Thinking
Platform technologies offer efficiency, but misalignment with target product profiles remains a common failure point in early-stage programs. Fit-for-purpose evaluation is critical.
Early CMC Strategy as a Value Driver
Proactive integration of CMC considerations at the discovery stage can accelerate timelines and improve the probability of clinical and regulatory success.
* This information is provided for general informational purposes only and does not constitute professional or regulatory advice. While efforts are made to ensure accuracy, SterPath does not guarantee completeness or assume responsibility for any errors or omissions.
Design based on Editorial by HTML5 UP --- Images sourced from Unsplash